+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-11-24Number of Pages: 117

Primary Immunodeficiency Diseases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


1. Introduction
     1.1. Report Description
     1.2. Research Methodology 
     1.3. Market Segmentation

2. Executive Summary
     2.1. Market Snapshot: Global Primary Immunodeficiency Diseases Market, 2014 and 2023E
     2.2. Global Primary Immunodeficiency Diseases Market Revenue, by Disease, 2014 (US$ Mn)
     2.3. Global Primary Immunodeficiency Diseases Market Revenue, by Subclass Disease, 2014 (US$ Mn)
     2.4. Global Primary Immunodeficiency Diseases Market Revenue, by Test, 2014 (US$ Mn)
     2.5. Global Primary Immunodeficiency Diseases Market Revenue, by Treatment, 2014 (US$ Mn)
     2.6. Comparative Analysis: Global Primary Immunodeficiency Diseases Market, by Geography 2014 & 2023 (Value %)

3. Market Overview
     3.1. Market Dynamics
     3.2. Drivers
            3.2.1. Government approval of new therapies for the PIDD treatment 
            3.2.2. Gradual increase in the incidence of primary immunodeficiency diseases globally
            3.2.3. Rising awareness campaigns drive demand for PIDD therapeutics or therapy
     3.3. Restraints
            3.3.1. Lack of Adequate Reimbursement and High Treatment Cost Hindering PIDD Market Growth
            3.3.2. Rising Number of Undiagnosed Patients Affecting Revenue Inflow
     3.4. Opportunities
            3.4.1. New Born Screening in Emerging Markets Expected to Provide New Opportunities
     3.5. Porter’s Five Forces Analysis, Global Primary Immunodeficiency Diseases Market
     3.6. Market Attractiveness Analysis, by Geography
     3.7. Competitive Landscape (Market Share Analysis), by Key Players
     3.8. Pipeline Analysis (Phase I and Phase II): Immunoglobulins
     3.9. Pipeline Analysis: (Phase III): Immunoglobulins (US$ Mn)

4. Primary Immunodeficiency Diseases Market, by Disease
     4.1. Introduction
     4.2. Antibody Deficiency
            4.2.1. Global Agammaglobulinaemia Market Revenue, 2013–2023, (US$ Mn)
            4.2.2. Global Common Variable Immune Deficiency Market Revenue, 2013–2023, (US$ Mn)
            4.2.3. Global Selective IgA Deficiency (SIgAD) Market Revenue, 2013–2023, (US$ Mn)
            4.2.4. Global IgG Subclass Deficiency Market Revenue, 2013–2023, (US$ Mn)
            4.2.5. Global Other Antibody Deficiency Market Revenue, 2013–2023, (US$ Mn)
     4.3. Cellular Immunodeficiency
            4.3.1. Global Ataxia Telangiectasia Market Revenue, 2013–2023, (US$ Mn)
            4.3.2. Global Hyper IgM Syndromes Market Revenue, 2013–2023, (US$ Mn)
            4.3.3. Global Wiskott-Aldrich Syndrome Market Revenue, 2013–2023, (US$ Mn)
            4.3.4. Global DiGeorge Syndrome Market Revenue, 2013–2023, (US$ Mn)
            4.3.5. Global Other Cellular Immunodeficiency Market Revenue, 2013–2023, (US$ Mn)
     4.4. Innate Immune Disorder
            4.4.1. Global Complement Deficiencies Market Revenue, 2013–2023, (US$ Mn)
            4.4.2. Global Hyper IgE Syndrome Market Revenue, 2013–2023, (US$ Mn)
            4.4.3. Global Other Innate Immune Disorder Market Revenue, 2013–2023, (US$ Mn)

5. Primary Immunodeficiency Diseases Market, by Test
     5.1. Introduction
     5.2. Global Primary Immunodeficiency Diseases Market Revenue, by Blood Test, 2013–2023 (US$ Mn)
     5.3. Global Primary Immunodeficiency Diseases Market Revenue, by Prenatal Testing, 2013–2023 (US$ Mn)

6. Primary Immunodeficiency Diseases Market, by Treatment
     6.1. Introduction
     6.2. Global Immunoglobulin Replacement Therapy Market Revenue, 2013–2023 (US$ Mn)
     6.3. Global Antibiotics Therapy Market Revenue, 2013–2023, (US$ Mn)
     6.4. Global Stem cell and Gene Therapy Market Revenue, 2013–2023, (US$ Mn)
     6.5. Global Other Primary Immunodeficiency Disease Treatments Market Revenue, 2013–2023, (US$ Mn)

7. Primary Immunodeficiency Diseases Market, by Geography
     7.1. Introduction
     7.2. North America Primary Immunodeficiency Diseases Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.3. Europe Primary Immunodeficiency Diseases Market, by Country, 2013–2023 (US$ Mn)
     7.4. Asia Pacific Primary Immunodeficiency Diseases Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.5. Rest of the World Primary Immunodeficiency Diseases Market Revenue, by Country, 2013–2023 (US$ Mn)

8. Recommendations

9. Company Profiles
     9.1. Baxter International, Inc.
     9.2. Biotest AG
     9.3. CSL Behring LLC
     9.4. Bio Products Laboratory Ltd.
     9.5. Kedrion S.p.A.
     9.6. LFB S.A.
     9.7. Octapharma AG
     9.8. Grifols S.A.


 
 
Back To Top